NedaKalhorMD

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Kalhor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas M.D. Anderson Cancer CenterSelective Pathology, 2006 - 2007
University of Texas Health Science Center at HoustonResidency, Pathology-Anatomic and Clinical, 2002 - 2006
Shahid Beheshti University of Medical SciencesClass of 1997

PubMed

Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms.
Alejandra G Serrano, Pedro Rocha, Cibelle Freitas Lima, Allison Stewart, Bingnan Zhang
NPJ Precision Oncology. 2024-11-19
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities.
C Allison Stewart, Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar
Clinical Cancer Research. 2024-10-15
Non-small cell lung carcinoma with ectopic gonadotropin production: A case report and review of the literature.
Sara L Mosaffa, Georgie Eapen, Neda Kalhor, Nour Sneige
Diagnostic Cytopathology. 2024-07-01

Journal Articles

Original Contribution Osteoclast-like Giant Cell Rich Carcinomas of the Lung: A Clinicopathological, Immunohistochemical, and Molecular Study of Three Cases
Neda Kalhor, Cesar A Moran, ScienceDirect
Thymomas with a Prominent Alveolar Growth Pattern: A Clinicopathologic and Immunohistochemical Study of 12 Cases
Cesar A Moran, Neda Kalhor, American Journal of Clinical Pathology
JAK1/STAT3 Activation Through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer
John D Minna, Jonathan M Kurie, J Jack Lee, Vassiliki A Papadimitrakopoulou, Neda Kalhor, Roy S Herbst, Clinical Cancer Research